News and Updates

Kalshi enters the biotech sector with new prediction markets for clinical trial outcomes. Discover the implications for investors and the medical industry.

New prediction markets allow traders to bet on clinical trial results and FDA approvals. Explore how these financial tools are changing biopharma R&D.

Eli Lilly acquires Atai-Beckley to innovate treatments for resistant depression and mental health. Discover how this move aims to transform psychiatric care.

MediciNova completes enrollment for the SEANOBI-ALS trial of MN-166. Explore how this potential neuroprotective therapy could change ALS treatment.

Explore the critical lessons learned from integrating Patient Research Partners into a 7-year clinical study to improve research design and retention.

Congo has launched a new clinical trial testing a Gilead antiviral as a post-exposure treatment for Ebola. Discover the potential impact on viral control.

New clinical research reveals that a cannabis-based treatment may effectively reduce agitation in dementia patients, offering a safer alternative to sedation.

Vivani Medical targets August for human trials of its new semaglutide implant. Learn how this novel delivery system could revolutionize metabolic care.

A major study by Stanford and Harvard experts ranks Doximity as a leader in clinical AI safety, highlighting critical gaps in current healthcare technology.

The FAST-02 clinical trial confirms that rapid, targeted radiation therapy provides significant pain relief for patients with chest wall bone metastases.